Erlotinib

Title	Average Rating
Audiologic and radiographic response of NF2-related vestibular schwannoma to erlotinib therapy.	70.00%
Is there a standard of care for the management of advanced pancreatic cancer?. Highlights from the Gastrointestinal Cancers Symp	60.00%
The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary stu	60.00%
Lessons learned in the development of targeted therapy for malignant gliomas	50.00%
The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary	50.00%

Languages